CEO: Timothy M. Mayleben

Sector: Healthcare
Industry:Biotechnology

Exchange: NASDAQ Global Market

Country: USA

Description: Esperion Therapeutics Inc is a pharmaceutical company focused on developing and commercializing oral, low-density lipoprotein cholesterol, or LDL-C, lowering therapies for the treatment of patients with elevated LDL-C.


Key numbers

Market Capitalization:1105923690
Shares Outstanding: 27327000
Float: 25374759.12
Next Earning Date:2020-02-18
TTm EPS: -3.5105
TTm Dividend Rate:
200 days moving average:42.99
50 days moving average: 38.22
One day percent Change: 1.25



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,